Pre-diagnostic smoking behaviour and poorer prognosis in a german breast cancer patient cohort - differential effects by tumour subtype, NAT2 status, BMI and alcohol intake

Cancer Epidemiology

Volumn 38, Issue 4, 2014, Pages 419-426

  Seibold, Petra ^a   Vrieling, Alina ^a,b   Heinz, Judith ^c   Obi, Nadia ^c   Sinn, Hans Peter ^d   Flesch Janys, Dieter ^c   Chang Claude, Jenny ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Acetylation status; Breast cancer survival; Effect modification; NAT2; Smoking; Tobacco

Indexed keywords

ALCOHOL; ANTINEOPLASTIC AGENT; ARYLAMINE ACETYLTRANSFERASE; NAT2 PROTEIN, HUMAN;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GERMANY; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING; ADVERSE EFFECTS; BREAST TUMOR; CAUCASIAN; DRINKING BEHAVIOR; GENETICS; GENOTYPE; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ALCOHOL DRINKING; ARYLAMINE N-ACETYLTRANSFERASE; BODY MASS INDEX; BREAST NEOPLASMS; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; GERMANY; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING;

EID: 84904546396     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2014.05.006     Document Type: Article

References (30)

1. Dal Maso L., Zucchetto A., Talamini R., Serraino D., Stocco C.F., Vercelli M., et al. Effect of obesity and other lifestyle factors on mortality in women with breast cancer. Int J Cancer 2008, 123:2188-2194.
2. Hellmann S.S., Thygesen L.C., Tolstrup J.S., Gronbaek M. Modifiable risk factors and survival in women diagnosed with primary breast cancer: results from a prospective cohort study. Eur J Cancer Prev 2010, 19:366-373.
3. Holmes M.D., Murin S., Chen W.Y., Kroenke C.H., Spiegelman D., Colditz G.A. Smoking and survival after breast cancer diagnosis. Int J Cancer 2007, 120:2672-2677.
4. Tominaga K., Andow J., Koyama Y., Numao S., Kurokawa E., Ojima M., et al. Family environment, hobbies and habits as psychosocial predictors of survival for surgically treated patients with breast cancer. Jpn J Clin Oncol 1998, 28:36-41.
5. Manjer J., Andersson I., Berglund G., Bondesson L., Garne J.P., Janzon L., et al. Survival of women with breast cancer in relation to smoking. Eur J Surg 2000, 166:852-858.
6. Braithwaite D., Izano M., Moore D.H., Kwan M.L., Tammemagi M.C., Hiatt R.A., et al. Smoking and survival after breast cancer diagnosis: a prospective observational study and systematic review. Breast Cancer Res Treat 2012, 136:521-533.
7. Sagiv S.K., Gaudet M.M., Eng S.M., Abrahamson P.E., Shantakumar S., Teitelbaum S.L., et al. Active and passive cigarette smoke and breast cancer survival. Ann Epidemiol 2007, 17:385-393.
8. Fentiman I.S., Allen D.S., Hamed H. Smoking and prognosis in women with breast cancer. Int J Clin Pract 2005, 59:1051-1054.
9. Yu G.P., Ostroff J.S., Zhang Z.F., Tang J., Schantz S.P. Smoking history and cancer patient survival: a hospital cancer registry study. Cancer Detect Prev 1997, 21:497-509.
10. Ewertz M., Gillanders S., Meyer L., Zedeler K. Survival of breast cancer patients in relation to factors which affect the risk of developing breast cancer. Int J Cancer 1991, 49:526-530.
11. Ambrosone C.B., Kropp S., Yang J., Yao S., Shields P.G., Chang-Claude J. Cigarette smoking, N-acetyltransferase 2 genotypes, and breast cancer risk: pooled analysis and meta-analysis. Cancer Epidemiol Biomarkers Prev 2008, 17:15-26.
12. Kobrinsky N.L., Klug M.G., Hokanson P.J., Sjolander D.E., Burd L. Impact of smoking on cancer stage at diagnosis. J Clin Oncol 2003, 21:907-913.
13. Manjer J., Malina J., Berglund G., Bondeson L., Garne J.P., Janzon L. Smoking associated with hormone receptor negative breast cancer. Int J Cancer 2001, 91:580-584.
14. Travier N., Agudo A., May A.M., Gonzalez C., Luan J., Besson H., et al. Smoking and body fatness measurements: a cross-sectional analysis in the EPIC-PANACEA study. Prev Med 2009, 49:365-373.
15. Ruf T., Nagel G., Altenburg H.P., Miller A.B., Thorand B. Food and nutrient intake, anthropometric measurements and smoking according to alcohol consumption in the EPIC Heidelberg study. Ann Nutr Metab 2005, 49:16-25.
16. Vrieling A., Buck K., Heinz J., Obi N., Benner A., Flesch-Janys D., et al. Pre-diagnostic alcohol consumption and postmenopausal breast cancer survival: a prospective patient cohort study. Breast Cancer Res Treat 2012, 136:195-207.
17. Kwan M.L., Chen W.Y., Kroenke C.H., Weltzien E.K., Beasley J.M., Nechuta S.J., et al. Pre-diagnosis body mass index and survival after breast cancer in the After Breast Cancer Pooling Project. Breast Cancer Res Treat 2012, 132:729-739.
18. Protani M., Coory M., Martin J.H. Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat 2010, 123:627-635.
19. Flesch-Janys D., Slanger T., Mutschelknauss E., Kropp S., Obi N., Vettorazzi E., et al. Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy. Int J Cancer 2008, 123:933-941.
20. Goldhirsch A., Wood W.C., Coates A.S., Gelber R.D., Thurlimann B., Senn H.J. Strategies for subtypes - dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol 2011, 22:1736-1747.
21. Cascorbi I., Brockmoller J., Mrozikiewicz P.M., Muller A., Roots I. Arylamine N-acetyltransferase activity in man. Drug Metab Rev 1999, 31:489-502.
22. Boukouvala S., Hein D.W., Grant D.M., Sim E., Minchin R.F., Agundez J.A.G., et al. The database of arylamine N-acetyltransferases (NATs) 2013, 2013.
23. Cascorbi I., Drakoulis N., Brockmoller J., Maurer A., Sperling K., Roots I. Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity. Am J Hum Genet 1995, 57:581-592.
24. Therneau T.M., Grambsch P.M. Modeling survival data. Extending the Cox modeled 2000, 75. Springer, New York.
25. Schemper M., Smith T.L. A note on quantifying follow-up in studies of failure time. Control Clin Trials 1996, 17:343-346.
26. Lin D.Y., Wei L.J., Ying Z. Checking the Cox model with cumulative sums of martingale-based residuals. Biometrika 1993, 80:557-572.
27. Warren G.W., Kasza K.A., Reid M.E., Cummings K.M., Marshall J.R. Smoking at diagnosis and survival in cancer patients. Int J Cancer 2013, 132:401-410.
28. Pfau W., Stone E.M., Brockstedt U., Carmichael P.L., Marquardt H., Phillips D.H. DNA adducts in human breast tissue: association with N-acetyltransferase-2 (NAT2) and NAT1 genotypes. Cancer Epidemiol Biomarkers Prev 1998, 7:1019-1025.
29. Sorlie T., Perou C.M., Tibshirani R., Aas T., Geisler S., Johnsen H., et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 2001, 98:10869-10874.
30. Yeager D.S., Krosnick J.A. The validity of self-reported nicotine product use in the 2001-2008 National Health and Nutrition Examination Survey. Med Care 2010, 48:1128-1132.